Loading...

Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia

Current treatment options as well as clinical efficacy are limited for chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML). In response to the pressing need for more efficacious treatment approaches and strategies to override drug resistance i...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Leuk Res
Main Authors: de la Puente, Pilar, Weisberg, Ellen, Muz, Barbara, Nonami, Atsushi, Luderer, Micah, Stone, Richard M., Melo, Junia V., Griffin, James D., Azab, Abdel Kareem
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5016250/
https://ncbi.nlm.nih.gov/pubmed/26413753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2015.09.005
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!